1. Home
  2. ZURA vs BCML Comparison

ZURA vs BCML Comparison

Compare ZURA & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.57

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$31.07

Market Cap

364.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZURA
BCML
Founded
2022
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
364.8M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
ZURA
BCML
Price
$5.57
$31.07
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$13.00
$34.00
AVG Volume (30 Days)
679.8K
45.2K
Earning Date
05-14-2026
04-23-2026
Dividend Yield
N/A
4.09%
EPS Growth
N/A
3.81
EPS
N/A
0.11
Revenue
N/A
N/A
Revenue This Year
N/A
$13.71
Revenue Next Year
N/A
$5.25
P/E Ratio
N/A
$282.36
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$26.78
52 Week High
$7.25
$34.98

Technical Indicators

Market Signals
Indicator
ZURA
BCML
Relative Strength Index (RSI) 54.20 45.19
Support Level $5.62 $27.80
Resistance Level $5.87 $32.86
Average True Range (ATR) 0.31 0.78
MACD -0.02 0.04
Stochastic Oscillator 53.13 75.79

Price Performance

Historical Comparison
ZURA
BCML

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.

Share on Social Networks: